Selected publications of CANCER-ID Partners
Multicentric Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows.
Clin Chem. 2019 Jun 24. pii: clinchem.2019.303271. doi: 10.1373/clinchem.2019.303271. [Epub ahead of print]
Authors: Kloten V, Neumann MHD, Di Pasquale F, Sprenger-Haussels M, Shaffer JM, Schlumpberger M, Herdean A, Betsou F, Ammerlaan W, Af Hällström T, Serkkola E, Forsman T, Lianidou E, Sjöback R, Kubista M, Bender S, Lampignano R, Krahn T, Schlange T; CANCER-ID consortium.
Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors
Journal for ImmunoTherapy of Cancer. (2019) 7:173
Authors: Menno Tamminga, Sanne de Wit, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Leon W. M. M. Terstappen and Harry J. M. Groen
Nat Rev Clin Oncol. 2018 Sep;15(9):541-563
Authors: Anfossi S, Babayan A, Pantel K, Calin GA
Authors: Riethdorf S, O'Flaherty L, Hille C, Pantel K
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
Authors: Bidard FC, Klaus Pantel et al
Scientific Reports, Volume 9, Article number: 4255 (2019
Authors: Peter Androvic, Nataliya Romanyuk, Lucia Urdzikova-Machova, Eva Rohlova, Mikael Kubista, Lukas Valihrach
Liquid Biopsy Preservation Solutions for Standardized Analytical Workflows - Venous Whole Blood and Plasma
Current Pathobiology Reports, October 2018
Computational and Structural Biotechnology Journal, June 2018
Authors: Neumann M H D, Bender S, Krahn T, Schlange T
PLOS ONE, October 2017
Authors: Zeune L, van Dalum G, Decraene C, Proudhon C,
Fehm T, Neubauer H, Rack B, Alunni-Fabbroni M, Terstappen L W M M, van Gils S A, Brune C
Tansl. Lung Canc. Res., August 2017
Authors: O’Flaherty L, Wikman H, Pantel K
Scale Space and Variational methods in Computer Vision, August 2017
Authors: Zeune L, van Gils S A, Terstappen L W M M, Brune C
Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer
Tansl. Lung Canc. Res., August 2017
Authors: Mohan S, Chemi F, Brady G
J. of Thoracic Disease, July 2017
Authors: Manicone M, Poggiana C, Facchinetti A, Zamarchi R
Molecular analysis of single circulating tumour cells following long-term storage of clinical samples
Mol. Oncol., July 2017
Authors: Mesquita B, Rothwell DG, Burt DJ, Chemi F, Fernandez-Gutierrez F, Slane-Tan D, Antonello J, Carter M, Carter L, Parry M, Franklin L, Marais R, Blackhall F, Dive C, Brady G.
A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups
Annals of Oncology, July 2017
Authors: Lindsay C.R. et al.
Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatmnet in ALK-Rearranged Non-Small Cell Lung Cancer Patients
Cancer Res, May 2017
Authors: Pailler E et al.
Nucleic Acids Res, July 2017
Authors: Androvich P, Vahlirach L, Elling J, Sjoeback R, Kubista M
Methods to determine limit of detection and limit of quantification in quantitative real-time PCR (qPCR)
Biomolecular Detection and Quantification, April 2017
Authors: Forootan A, Sjoeback R, Bjoerkman J, Sjoegreen B, Linz L, Kubista M
Nature Reviews, March 2017
Authors: Siravegna G, Marsoni S, Siena S, Bardelli A
Int. J. Clin. Oncol., February 2017
Authors: Cabel L, Proudhon C, Gortais H, Loirat D, Coussy F, Pierga JY, Bidard FC.
Eur J Surg Oncol., January 2017
Authors: Cabel L, Proudhon C, Mariani P, Tzanis D, Beinse G, Bieche I, Pierga JY, Bidard FC.
Sci. Rep., December 2016
Authors: Kuske a et al.
J. Mol. Med., December 2016
Authors: Francart ME, Lambert J, Vanwynsberghe AM, Thompson EW, Bourcy M, Polette M, Gilles C.
PLoS Med., December 2016
Authors: Pantel K
Expert Review of Molecular Diagnostics, October 2016
Authors: Swennenhuis JF, van Dalum G, Zeune LL, Terstappen LWMM
Perspektiven der Onkologie, September 2016
Authors: Gorges TM and Pantel K
Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells
Cancer Diagnostics, September 2016
Authors: Gorges TM, Kuske A, Röck K, Mauermann O, Müller V, Peine S, Verpoort K, Novosadova V, Kubista M, Riethdorf S, Pantel K
Nature Genetics, August 2016
Authors: Peter Ulz et al.
ACS Appl Mater Interfaces, August 2016
Authors: Andrée KC, Barradas AMC, Nguyen AT, Mentink A, Stojanovic I, Baggerman J, van Dalum J, van Rijn CJM, and Terstappen LWMM
Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer
Mol Oncol., July 2016
Authors: Gasch C, Oldopp T, Mauermann O,Gorges TM, Andreas A, Coith C, Mueller V, Fehm T, Janni W, Pantel K, Riehtdorf S
Sci Rep., June 2016
Authors: Hanssen et al.
Improved dectection of circulating tumor cells in metastatic colorectal cancer by the combination of the CellSearch® System and the AdnaTest®
PLOS ONE, May 2016
Authors: Gorges TM, Stein A, Quidde J, Hauch S, Röck K, Riehtdorf S, Joosse S, Pantel K
Mol Oncol, April 2016
Authors: Zeune L, van Dalum G, Terstappen LWMM, van Gils SA, Brune C
Mol Oncol, March 2016
Authors: Andree KC, van Dalum G, Terstappen LW.
Molecular Oncology, December 2015
Authors: Siravegna G, Bardelli A
Heterogeneous PSMA expression on circulating tumor cells - a potential basis for stratification and monitoring of PSMA-directed therpies on prostate cancer
Oncotarget, April 2016
Authors: Gorges TM, Riethdorf S, von AHsen O, Nastaly P, Röck K, Boede M, Peine S, Kuske A, Schmid E, Kneip C, König F, Rudolph M, Pantel K
Biopreserv Biobank, April 2016
Authors: Ammerlaan W, Betsou F
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations
Science Translational Medicine, February 2016
Authors: Arena S, Siravegna G, Mussolin B, Kearns JD, Wolf B, Misale S, Lazzari L, Bertotti A, Trusolino L, Adjei A, Montagut C, Nicolantonio F, Nering R, Bardelli A
Pharmacogenomics, January 2016
Authors: Schlange T and Pantel K
Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells.
Clin Cancer Res., December 2015
Authors: Gorges TM, Penkalla N, Schalk T, Joosse S, Riethdorf S, Tucholski J, Lucke K, Wikman H, Jackson SM, Brychter N, von Ahsen O, Schumann C, Krahn T, Pantel K.
A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells.
Int J Cancer, January 2016
Authors: Hvichia GE, Parveen Z, Wagner C, Janning M, Quidde J, Stein A, Müller V, Loges S, Neves RP, Stoecklein NH, Wikman H, Riethdorf S, Pantel K, Gorges TM
Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer.
Analyst, January 2016
Authors: Chudziak J, Burt DJ, Mohan S, Rothwell DG, Mesquita B, Antonello J, Dalby S, Ayub M, Priest L, Carter L, Krebs MG, Blackhall F, Dive C, Brady G.
Expert Review of Molecular Diagnostics, December 2015
Authors: Stoecklein N, Fischer J, Niederacher D, Terstappem LWMM
Molecular Oncology, November 2015
Authors:Rothwell DG, Smith N, Morris D, Leong HS, Li Y, Hollebecque A, Ayub M, Carter L, Antonello J, Franklin L, Miller C, Blackhall F, Dive C, Brady G.
Nature Reviews, October 2015
Authors: Khusru Asadullah, Andreas Busch, Matthias Gottwald, Petra Teinke and Lilla Landeck
genes, October 2015
Authors: Constantin F. Pixberg, Wolfgang A. Schulz, Nikolas H. Stoecklein and Rui P. L. Neves
Clin Chem, September 2015
Authors: H. Schwarzenbach, A. Machado da Silva, G. Calin and K. Pantel
Clin Cancer Res, June 2015
Authors: W. Jeffrey Allard and Leon W.M.M. Terstappen
Oncogene, June 2015
Authors: K. Pantel and M. Speicher